Procalcitonin: Weighing the Benefits and the Costs

episode

The SHEA Podcast not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

A.I. Safety Goes Mainstream + a ‘Hard Fork’ Exit AMA 1h 25m · 18 Sep 2026 · Hard Fork

Layoffs at the Kansas City Star will hurt local communities 15 min · 18 Sep 2026 · Kansas City Today

Buying property with family or a partner, what could go wrong ... 44 min · 17 Sep 2026 · The Curve

How the 2026 Midterms Will ACTUALLY Unfold for Republicans 1h 4m · 17 Sep 2026 · Next Up with Mark Halperin

The Greatest Wrestling Environments 21 min · 17 Sep 2026 · Busted Open

Robert Harris On Returning To Ancient Rome For His Latest Novel 15 min · 17 Sep 2026 · The Last Word with Matt Cooper

Report any issue

Source

Recorded28 Aug 2019

Publisherfeeds.soundcloud.com ↗

Handlerec:4493364

Show notes

Speakers: - Tom File, MD, MSc, MACP, FIDSA, FCCP - Shira Doron, MD, FIDSA - Moderator: Whitney Buckel, PharmD Summary: Procalcitonin has been shown in numerous trials to reduce unnecessary antibiotic use associated with sepsis and respiratory infections and is a diagnostic tool that antibiotic stewardship programs can use to improve antibiotic use. This episode discussed the role of procalcitonin in antibiotic stewardship programs and examples of intervention to improve the use of procalcitonin.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in